Latest On Sutro Biopharma, Inc (STRO):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-15 15:17 EST | News | Sutro Biopharma GAAP EPS of -$0.85, revenue of $12.7M | N/A |  |
| 2023-05-03 15:49 EST | News | Sutro, Mersana jump after Immunogen data for ovarian cancer therapy | N/A | |
| 2023-04-11 19:04 EST | News | Sutro: Too Little, Too Late For STRO-002, But Platform Is Interesting | N/A | |
| 2023-03-31 10:48 EST | News | Sutro Biopharma GAAP EPS of -$2.35 beats by $0.16, revenue of $67.8M misses by $0.57M | N/A | |
| 2023-03-22 01:51 EST | News | Sutro Biopharma stock slides as transferred to Equal Weight at Wells Fargo | N/A | |
| 2023-02-28 10:05 EST | News | Sutro Biopharma appoints Borgman as Chief Medical Officer | N/A | |
| 2022-12-20 18:43 EST | News | Vaxcyte acquires option from Sutro Biopharma to expand rights to make cell-free extract | N/A | |
| 2022-11-08 19:34 EST | News | Sutro Biopharma GAAP EPS of -$0.37 misses by $0.08, revenue of $25.14M misses by $10.62M | N/A | |
| 2022-08-16 14:27 EST | News | Sutro Biopharma: Partnership Progress Warrants Exposure | N/A | |
| 2022-08-09 08:23 EST | News | Sutro Biopharma GAAP EPS of -$0.55, revenue of $28.1M | N/A | |
| 2022-07-26 21:24 EST | News | Sutro to get $10M payment from Merck after first patient dosed in collaboration trial | N/A | |
| 2022-06-28 10:31 EST | News | Sutro Biopharma soars ~50% after announcing worldwide strategic collaboration with Astellas Pharma | N/A | |
| 2022-05-09 17:15 EST | News | Sutro Biopharma GAAP EPS of -$0.84 misses by $0.08, revenue of $5.89M misses by $4.57M | N/A | |
| 2022-02-28 19:19 EST | News | Sutro Biopharma GAAP EPS of -$2.29 misses by $0.13, revenue of $61.88M beats by $0.16M | N/A | |
| 2022-01-06 18:39 EST | News | Sutro at a 52-week low as analysts weigh in on safety data for cancer drug | N/A | |
| 2022-01-06 02:58 EST | News | Sutro posts early-stage data for ovarian cancer drug indicating 33% ORR | N/A | |
| 2021-12-27 20:30 EST | News | Sutro Bio inks licensing deal for STRO-002 in Greater China | N/A | |
| 2021-12-27 20:30 EST | News | Sutro; A Biotech To Watch With A Catalyst Rapidly Approaching | N/A | |
| 2021-12-06 22:52 EST | News | Sutro Biopharma (STRO) Presents At 4th Annual Evercore ISI HealthCONx Conference - Slideshow | N/A | |
| 2021-12-06 22:52 EST | News | Sutro Biopharma (STRO) Presents At Piper Sandler 33rd Annual Virtual Healthcare Conference - Slideshow | N/A | |
| 2021-12-06 22:52 EST | News | Sutro Biopharma (STRO) Presents At Jefferies London Healthcare Conference - Slideshow | N/A | |
| 2021-11-23 08:45 EST | News | Sutro Biopharma (STRO) Presents At 2021 Virtual Healthcare Conference - Slideshow | N/A | |
| 2021-11-10 16:26 EST | News | Sutro Biopharma EPS misses by $0.02, misses on revenue | N/A | |
| 2021-10-12 13:29 EST | News | Sutro Biopharma and BioNova ink collaboration agreement for STRO-001 in Greater China | N/A | |
| 2021-10-01 22:07 EST | News | Sutro Biopharma and Merck extend research term for cytokine derivative program | N/A | |
| 2021-09-11 04:32 EST | News | Sutro Biopharma (STRO) Presents At 2021 Virtual Wells Fargo Healthcare Conference | N/A | |
| 2021-08-18 17:50 EST | News | Sutro Biopharma nabs FDA Fast Track Designation for ovarian cancer therapy | N/A | |
| 2021-08-09 15:28 EST | News | Sutro Biopharma reports Q2 results | N/A | |
| 2021-07-22 02:42 EST | News | Sutro Biopharma initiated buy at H.C. Wainwright citing ADC candidates | N/A | |
| 2021-05-07 16:03 EST | News | Sutro Biopharma EPS misses by $0.04, beats on revenue | N/A | |
| 2021-04-16 02:20 EST | News | Sutro Biopharma (STRO) Presents At 20th Annual Needham Virtual Healthcare Conference - Slideshow | N/A | |
| 2021-04-15 08:22 EST | News | Sutro Biopharma earns milestone payment from Merck collaboration | N/A | |
| 2021-03-19 02:57 EST | News | Sutro Biopharma EPS misses by $1.07, revenue in-line | N/A | |
| 2021-03-03 12:30 EST | Analyst Rating | The Analyst Target Price has decreased from $31.14 to $29.43. | Neutral | |
| 2021-02-24 14:49 EST | News | Bristol-Myers receives FDA’s orphan drug designation for multiple myeloma therapy | N/A | |
| 2021-01-29 08:37 EST | Analyst Rating | The Analyst Target Price has increased from $29.29 to $31.14. | Buy | |
| 2021-01-22 08:39 EST | Analyst Rating | The Analyst Target Price has increased from $28.57 to $29.29. | Buy | |
| 2021-01-21 14:56 EST | News | Dosing underway in Sutro Biopharma's early-stage ovarian cancer trial with STRO-002 | N/A | |
| 2021-01-06 11:06 EST | News | Sutro: Leading Cell Free Protein Synthesis Company With Promising Early Data | N/A | |
| 2020-12-15 13:03 EST | Analyst Rating | The Analyst Target Price has increased from $27.57 to $28.57. | Buy | |
| 2020-12-11 12:45 EST | Analyst Rating | The Analyst Target Price has increased from $26.86 to $27.57. | Buy | |
| 2020-12-09 07:03 EST | News | Sutro Biopharma (STRO) Investor Presentation - Slideshow | N/A | |
| 2020-12-09 07:03 EST | News | Sutro Biopharma prices $126M public offering | N/A | |
| 2020-12-08 12:46 EST | News | Sutro Biopharma down after STRO-001 data in blood cancer study | N/A | |
| 2020-12-08 12:46 EST | News | Sutro Biopharma -4.6% after filing to offer 5M shares | N/A | |
| 2020-12-07 21:12 EST | Analyst Rating | The Analyst Target Price has increased from $21.57 to $26.86. | Buy | |
| 2020-12-04 12:27 EST | News | Sutro +23.5% as ovarian cancer drug study offers encouraging interim data | N/A | |
| 2020-12-04 09:03 EST | Analyst Rating | The Analyst Target Price has increased from $21 to $21.57. | Neutral | |
| 2020-11-28 06:08 EST | News | Seeking Alpha Catalyst Watch | N/A | |
| 2020-11-26 21:40 EST | Financials | Company financials have been released. | Neutral | |
About Sutro Biopharma, Inc (STRO):
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF. The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers. It has collaboration and license agreement with Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused primarily on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.
General
- Name Sutro Biopharma, Inc
- Symbol STRO
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 182
- Fiscal Year EndDecember
- IPO Date2018-09-27
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.sutrobio.com
View More
Valuation
- Trailing PE 54.26
- Price/Sales (Trailing 12 Mt.) 14.95
- Price/Book (Most Recent Quarter) 4.48
- Enterprise Value Revenue 18.27
- Enterprise Value EBITDA 41.71
View More
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate -$0.56
- Profit Margin 28%
- Operating Margin -134%
- Return on Assets -16%
- Return on Equity 7%
- Revenue 45.75 million
- Earnings Per Share $0.44
- Revenue Per Share $1.62
- Gross Profit -22876000
- Quarterly Earnings Growth 45.2%
View More
Highlights
- Market Capitalization 1.09 billion
- EBITDA -36933000
- PE Ratio -3.01
- Analyst Target Price $29.43
- Book Value Per Share $6.41
View More
Share Statistics
- Shares Outstanding 45.61 million
- Shares Float 34.47 million
- % Held by Insiders 1111%
- % Held by Institutions 88.44%
- Shares Short 1.14 million
- Shares Short Prior Month 1.03 million
- Short Ratio 2.56
- Short % of Float 3%
- Short % of Shares Outstanding 3%
View More
Technicals
- Beta 0.79
- 52 Week High $28.3
- 52 Week Low $6.91
- 50 Day Moving Average 23.26
- 200 Day Moving Average 18.4
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Sutro Biopharma, Inc (STRO) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Sutro Biopharma, Inc (STRO) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-11-05 | $17.82 million | $0.45 | -$0.51 | 188.74% |
| 2020-06-30 | 2020-08-06 | $N/A | $0.94 | -$0.64 | 246.01% |
| 2020-03-31 | 2020-05-11 | $7.15 million | -$0.84 | -$0.69 | -21.99% |
| 2019-12-31 | 2020-03-16 | $11.31 million | -$0.64 | -$0.69 | 7.81% |
| 2019-09-30 | 2019-11-08 | $12.28 million | -$0.56 | -$0.65 | 14.45% |
| 2019-06-30 | 2019-08-14 | $10.53 million | -$0.60 | -$0.62 | 3.41% |
| 2019-03-31 | 2019-05-15 | $8.63 million | -$0.62 | -$0.61 | -2.06% |
| 2018-12-31 | 2018-12-31 | $19.09 million | -$0.26 | -$0.63 | 58.73% |
| 2018-09-30 | 2018-11-14 | $7.84 million | -$0.45 | -$0.85 | 47.5% |
Sutro Biopharma, Inc (STRO) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Sutro Biopharma, Inc (STRO) Chart:
Sutro Biopharma, Inc (STRO) News:
Below you will find a list of latest news for Sutro Biopharma, Inc (STRO) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Sutro Biopharma, Inc (STRO) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-20 | 2.5 | 0 | CALL | 0 | 0 | 1262.17 | TRUE | 0 | 0 |
| 2026-03-20 | 5 | 0 | CALL | 0 | 0 | 1129.74 | TRUE | 0 | 0 |
| 2026-03-20 | 7.5 | 0 | CALL | 0 | 0 | 988.36 | TRUE | 0 | 0 |
| 2026-03-20 | 10 | 0 | CALL | 0 | 0 | 735.29 | TRUE | 0 | 0 |
| 2026-03-20 | 12.5 | 11 | CALL | 0 | 1 | 598.61 | TRUE | 0 | 0 |
| 2026-03-20 | 15 | 2.25 | CALL | 0 | 5 | 374.08 | TRUE | 0 | 0 |
| 2026-03-20 | 17.5 | 5.8 | CALL | 0 | 1 | 273.31 | TRUE | 0 | 0 |
| 2026-03-20 | 20 | 2.1 | CALL | 0 | 19 | 232.87 | TRUE | 0 | 0 |
| 2026-03-20 | 22.5 | 0 | CALL | 0 | 0 | 225.94 | TRUE | 0 | 0 |
| 2026-03-20 | 25 | 0 | CALL | 0 | 0 | 563.23 | FALSE | 0 | 0 |
| 2026-03-20 | 30 | 0 | CALL | 0 | 0 | 720.82 | FALSE | 0 | 0 |
| 2026-03-20 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-03-20 | 5 | 0.01 | PUT | 0 | 10 | 706.05 | FALSE | 0 | 0 |
| 2026-03-20 | 7.5 | 0.01 | PUT | 71 | 101 | 427.76 | FALSE | 0.01 | 0 |
| 2026-03-20 | 10 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-03-20 | 12.5 | 0.1 | PUT | 0 | 290 | 306.03 | FALSE | 0 | 0 |
| 2026-03-20 | 15 | 0.75 | PUT | 0 | 134 | 441.4 | FALSE | 0 | 0 |
| 2026-03-20 | 17.5 | 0.2 | PUT | 0 | 90 | 337.04 | FALSE | 0 | 0 |
| 2026-03-20 | 20 | 0.3 | PUT | 0 | 35 | 735.11 | FALSE | 0 | 0 |
| 2026-03-20 | 22.5 | 1.26 | PUT | 0 | 6 | 204.42 | FALSE | 0 | 0 |
| 2026-03-20 | 25 | 0 | PUT | 0 | 0 | 162.37 | TRUE | 0 | 0 |
| 2026-03-20 | 30 | 6 | PUT | 0 | 10 | 0 | TRUE | 0 | 0 |
| 2026-04-17 | 2.5 | 0 | CALL | 0 | 0 | 596.05 | TRUE | 0 | 0 |
| 2026-04-17 | 5 | 0 | CALL | 0 | 0 | 396.99 | TRUE | 0 | 0 |
| 2026-04-17 | 7.5 | 0 | CALL | 0 | 0 | 303.63 | TRUE | 0 | 0 |
| 2026-04-17 | 10 | 0 | CALL | 0 | 0 | 227.35 | TRUE | 0 | 0 |
| 2026-04-17 | 12.5 | 0 | CALL | 0 | 0 | 209.26 | TRUE | 0 | 0 |
| 2026-04-17 | 15 | 0 | CALL | 0 | 0 | 157.61 | TRUE | 0 | 0 |
| 2026-04-17 | 17.5 | 0 | CALL | 0 | 0 | 134.65 | TRUE | 0 | 0 |
| 2026-04-17 | 20 | 0 | CALL | 0 | 0 | 119.73 | TRUE | 0 | 0 |
| 2026-04-17 | 22.5 | 0 | CALL | 0 | 2 | 127.71 | TRUE | 0 | 0 |
| 2026-04-17 | 25 | 4.2 | CALL | 0 | 2 | 118.37 | FALSE | 0 | 0 |
| 2026-04-17 | 30 | 0 | CALL | 0 | 0 | 250.48 | FALSE | 0 | 0 |
| 2026-04-17 | 35 | 0 | CALL | 0 | 0 | 288.67 | FALSE | 0 | 0 |
| 2026-04-17 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-04-17 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-04-17 | 7.5 | 0.1 | PUT | 20 | 0 | 209.17 | FALSE | 0.1 | 0 |
| 2026-04-17 | 10 | 0.1 | PUT | 10 | 0 | 160.27 | FALSE | 0.1 | 0 |
| 2026-04-17 | 12.5 | 0.6 | PUT | 0 | 173 | 141.37 | FALSE | 0 | 0 |
| 2026-04-17 | 15 | 0.5 | PUT | 0 | 3 | 403.02 | FALSE | 0 | 0 |
| 2026-04-17 | 17.5 | 0.8 | PUT | 0 | 1 | 158.81 | FALSE | 0 | 0 |
| 2026-04-17 | 20 | 0 | PUT | 0 | 0 | 261.14 | FALSE | 0 | 0 |
| 2026-04-17 | 22.5 | 0 | PUT | 0 | 0 | 116.71 | FALSE | 0 | 0 |
| 2026-04-17 | 25 | 0 | PUT | 0 | 0 | 100.86 | TRUE | 0 | 0 |
| 2026-04-17 | 30 | 0 | PUT | 0 | 0 | 88.5 | TRUE | 0 | 0 |
| 2026-04-17 | 35 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-05-15 | 2.5 | 0.2 | CALL | 0 | 0 | 406.26 | TRUE | 0 | 0 |
| 2026-05-15 | 5 | 0 | CALL | 0 | 0 | 270.92 | TRUE | 0 | 0 |
| 2026-05-15 | 7.5 | 3 | CALL | 0 | 1 | 213.69 | TRUE | 0 | 0 |
| 2026-05-15 | 10 | 0 | CALL | 0 | 0 | 153.27 | TRUE | 0 | 0 |
| 2026-05-15 | 12.5 | 4.2 | CALL | 0 | 4 | 175.41 | TRUE | 0 | 0 |
| 2026-05-15 | 15 | 4 | CALL | 0 | 3 | 150.38 | TRUE | 0 | 0 |
| 2026-05-15 | 17.5 | 0 | CALL | 0 | 1 | 137.45 | TRUE | 0 | 0 |
| 2026-05-15 | 20 | 3.8 | CALL | 0 | 3 | 129 | TRUE | 0 | 0 |
| 2026-05-15 | 22.5 | 6.2 | CALL | 0 | 2 | 120.21 | TRUE | 0 | 0 |
| 2026-05-15 | 25 | 1.15 | CALL | 0 | 1 | 120.08 | FALSE | 0 | 0 |
| 2026-05-15 | 30 | 0 | CALL | 0 | 0 | 118.71 | FALSE | 0 | 0 |
| 2026-05-15 | 35 | 0 | CALL | 0 | 0 | 210.32 | FALSE | 0 | 0 |
| 2026-05-15 | 2.5 | 0.05 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2026-05-15 | 5 | 0 | PUT | 0 | 0 | 1313.65 | FALSE | 0 | 0 |
| 2026-05-15 | 7.5 | 0.25 | PUT | 0 | 140 | 205.47 | FALSE | 0 | 0 |
| 2026-05-15 | 10 | 0.75 | PUT | 0 | 14 | 220.47 | FALSE | 0 | 0 |
| 2026-05-15 | 12.5 | 0.6 | PUT | 0 | 376 | 167.5 | FALSE | 0 | 0 |
| 2026-05-15 | 15 | 1 | PUT | 2 | 2 | 127.98 | FALSE | 1 | 0 |
| 2026-05-15 | 17.5 | 0 | PUT | 0 | 1 | 153.55 | FALSE | 0 | 0 |
| 2026-05-15 | 20 | 1.95 | PUT | 0 | 2 | 121.4 | FALSE | 0 | 0 |
| 2026-05-15 | 22.5 | 0 | PUT | 0 | 0 | 109.58 | FALSE | 0 | 0 |
| 2026-05-15 | 25 | 0 | PUT | 0 | 0 | 108.93 | TRUE | 0 | 0 |
| 2026-05-15 | 30 | 0 | PUT | 0 | 0 | 101.97 | TRUE | 0 | 0 |
| 2026-05-15 | 35 | 0 | PUT | 0 | 0 | 94.05 | TRUE | 0 | 0 |
| 2026-08-21 | 2.5 | 14.32 | CALL | 0 | 1 | 227.9 | TRUE | 0 | 0 |
| 2026-08-21 | 5 | 0 | CALL | 0 | 0 | 168.11 | TRUE | 0 | 0 |
| 2026-08-21 | 7.5 | 0 | CALL | 0 | 0 | 138.4 | TRUE | 0 | 0 |
| 2026-08-21 | 10 | 9.06 | CALL | 0 | 3 | 125.85 | TRUE | 0 | 0 |
| 2026-08-21 | 12.5 | 0 | CALL | 0 | 0 | 125.76 | TRUE | 0 | 0 |
| 2026-08-21 | 15 | 12.49 | CALL | 0 | 2 | 123.85 | TRUE | 0 | 0 |
| 2026-08-21 | 17.5 | 5.1 | CALL | 0 | 4 | 119.3 | TRUE | 0 | 0 |
| 2026-08-21 | 20 | 4.05 | CALL | 0 | 15 | 114.37 | TRUE | 0 | 0 |
| 2026-08-21 | 22.5 | 7.47 | CALL | 0 | 1 | 112.84 | TRUE | 0 | 0 |
| 2026-08-21 | 25 | 2.85 | CALL | 0 | 2 | 111.67 | FALSE | 0 | 0 |
| 2026-08-21 | 30 | 5.3 | CALL | 0 | 4 | 112.83 | FALSE | 0 | 0 |
| 2026-08-21 | 35 | 3.72 | CALL | 0 | 2 | 113.9 | FALSE | 0 | 0 |
| 2026-08-21 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-08-21 | 5 | 0 | PUT | 0 | 0 | 848.1 | FALSE | 0 | 0 |
| 2026-08-21 | 7.5 | 0 | PUT | 0 | 0 | 388.02 | FALSE | 0 | 0 |
| 2026-08-21 | 10 | 1.6 | PUT | 0 | 2 | 287.74 | FALSE | 0 | 0 |
| 2026-08-21 | 12.5 | 2.45 | PUT | 0 | 4 | 227.46 | FALSE | 0 | 0 |
| 2026-08-21 | 15 | 0 | PUT | 0 | 0 | 121.7 | FALSE | 0 | 0 |
| 2026-08-21 | 17.5 | 0 | PUT | 0 | 0 | 111.07 | FALSE | 0 | 0 |
| 2026-08-21 | 20 | 0 | PUT | 0 | 0 | 109.21 | FALSE | 0 | 0 |
| 2026-08-21 | 22.5 | 0 | PUT | 0 | 0 | 109.55 | FALSE | 0 | 0 |
| 2026-08-21 | 25 | 11.58 | PUT | 0 | 1 | 109.04 | TRUE | 0 | 0 |
| 2026-08-21 | 30 | 0 | PUT | 0 | 0 | 108.71 | TRUE | 0 | 0 |
| 2026-08-21 | 35 | 0 | PUT | 0 | 0 | 103.8 | TRUE | 0 | 0 |
Latest STRO Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 220 | $3.585 |
| Jun 13, 2022 7:59 PM EST | 84 | $3.585 |
| Jun 13, 2022 7:59 PM EST | 100 | $3.585 |
| Jun 13, 2022 7:59 PM EST | 65 | $3.585 |
| Jun 13, 2022 7:59 PM EST | 10 | $3.585 |
Sutro Biopharma, Inc (STRO) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120039220/0001209191-20-039220-index.htm |
| 2019-10-08 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1382101/000000000019014405/0000000000-19-014405-index.htm |
| 2020-05-22 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1382101/000092189520001581/0000921895-20-001581-index.htm |
| 2020-08-28 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1382101/000093583620000485/0000935836-20-000485-index.htm |
| 2018-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000110465918059933/0001104659-18-059933-index.htm |
| 2018-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000110465918060241/0001104659-18-060241-index.htm |
| 2018-10-04 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1382101/000110465918060573/0001104659-18-060573-index.htm |
| 2020-02-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1382101/000110465920013796/0001104659-20-013796-index.htm |
| 2020-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1382101/000110465920019043/0001104659-20-019043-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1382101/000110465920020195/0001104659-20-020195-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1382101/000110465920021714/0001104659-20-021714-index.htm |
| 2020-08-25 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1382101/000110465920098064/0001104659-20-098064-index.htm |
| 2018-10-04 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1382101/000114420418052437/0001144204-18-052437-index.htm |
| 2019-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1382101/000114420419006659/0001144204-19-006659-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1382101/000114420419008119/0001144204-19-008119-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1382101/000114420419008329/0001144204-19-008329-index.htm |
| 2018-10-09 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1382101/000119312518295955/0001193125-18-295955-index.htm |
| 2018-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1382101/000119312518322690/0001193125-18-322690-index.htm |
| 2018-11-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1382101/000119312518326967/0001193125-18-326967-index.htm |
| 2019-10-04 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1382101/000119312519262726/0001193125-19-262726-index.htm |
| 2019-10-09 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1382101/000119312519265124/0001193125-19-265124-index.htm |
| 2019-10-11 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1382101/000119312519266765/0001193125-19-266765-index.htm |
| 2020-05-11 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1382101/000119312520139053/0001193125-20-139053-index.htm |
| 2020-05-12 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1382101/000119312520140570/0001193125-20-140570-index.htm |
| 2018-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919118052480/0001209191-18-052480-index.htm |
| 2018-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919118052481/0001209191-18-052481-index.htm |
| 2018-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919118052482/0001209191-18-052482-index.htm |
| 2018-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919118052483/0001209191-18-052483-index.htm |
| 2018-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919118052487/0001209191-18-052487-index.htm |
| 2018-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919118052490/0001209191-18-052490-index.htm |
| 2018-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919118052491/0001209191-18-052491-index.htm |
| 2018-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919118052492/0001209191-18-052492-index.htm |
| 2018-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919118052493/0001209191-18-052493-index.htm |
| 2018-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919118052495/0001209191-18-052495-index.htm |
| 2018-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919118052496/0001209191-18-052496-index.htm |
| 2018-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919118052826/0001209191-18-052826-index.htm |
| 2018-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919118052831/0001209191-18-052831-index.htm |
| 2018-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919118052833/0001209191-18-052833-index.htm |
| 2018-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919118052835/0001209191-18-052835-index.htm |
| 2018-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919118052837/0001209191-18-052837-index.htm |
| 2018-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919118052839/0001209191-18-052839-index.htm |
| 2018-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919118052841/0001209191-18-052841-index.htm |
| 2018-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919118052843/0001209191-18-052843-index.htm |
| 2018-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919118052848/0001209191-18-052848-index.htm |
| 2018-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919118052851/0001209191-18-052851-index.htm |
| 2018-11-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919118058332/0001209191-18-058332-index.htm |
| 2018-11-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919118058335/0001209191-18-058335-index.htm |
| 2019-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119006200/0001209191-19-006200-index.htm |
| 2019-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119006201/0001209191-19-006201-index.htm |
| 2019-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119006202/0001209191-19-006202-index.htm |
| 2019-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119006203/0001209191-19-006203-index.htm |
| 2019-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119006204/0001209191-19-006204-index.htm |
| 2019-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119006206/0001209191-19-006206-index.htm |
| 2019-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119006208/0001209191-19-006208-index.htm |
| 2019-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119010244/0001209191-19-010244-index.htm |
| 2019-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119038094/0001209191-19-038094-index.htm |
| 2019-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119038097/0001209191-19-038097-index.htm |
| 2019-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119038100/0001209191-19-038100-index.htm |
| 2019-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119038101/0001209191-19-038101-index.htm |
| 2019-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119038102/0001209191-19-038102-index.htm |
| 2019-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119038103/0001209191-19-038103-index.htm |
| 2019-06-26 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119039122/0001209191-19-039122-index.htm |
| 2019-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119039123/0001209191-19-039123-index.htm |
| 2019-08-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119047755/0001209191-19-047755-index.htm |
| 2019-09-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119048831/0001209191-19-048831-index.htm |
| 2019-09-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119051116/0001209191-19-051116-index.htm |
| 2019-09-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119051117/0001209191-19-051117-index.htm |
| 2019-09-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119051118/0001209191-19-051118-index.htm |
| 2019-09-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119051119/0001209191-19-051119-index.htm |
| 2019-09-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119051122/0001209191-19-051122-index.htm |
| 2019-09-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119051124/0001209191-19-051124-index.htm |
| 2019-10-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119054572/0001209191-19-054572-index.htm |
| 2019-11-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119058353/0001209191-19-058353-index.htm |
| 2019-12-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919119062036/0001209191-19-062036-index.htm |
| 2020-01-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120002565/0001209191-20-002565-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120002569/0001209191-20-002569-index.htm |
| 2020-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120005159/0001209191-20-005159-index.htm |
| 2020-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120005798/0001209191-20-005798-index.htm |
| 2020-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120005806/0001209191-20-005806-index.htm |
| 2020-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120005808/0001209191-20-005808-index.htm |
| 2020-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120005810/0001209191-20-005810-index.htm |
| 2020-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120005812/0001209191-20-005812-index.htm |
| 2020-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120005814/0001209191-20-005814-index.htm |
| 2020-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120013478/0001209191-20-013478-index.htm |
| 2020-03-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120021438/0001209191-20-021438-index.htm |
| 2020-04-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120025882/0001209191-20-025882-index.htm |
| 2020-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120029243/0001209191-20-029243-index.htm |
| 2020-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120029244/0001209191-20-029244-index.htm |
| 2020-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120029246/0001209191-20-029246-index.htm |
| 2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120032414/0001209191-20-032414-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120035026/0001209191-20-035026-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120035027/0001209191-20-035027-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120035028/0001209191-20-035028-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120035030/0001209191-20-035030-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120035036/0001209191-20-035036-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120035037/0001209191-20-035037-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120035058/0001209191-20-035058-index.htm |
| 2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120039220/0001209191-20-039220-index.htm |
| 2020-07-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120043857/0001209191-20-043857-index.htm |
| 2020-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120047981/0001209191-20-047981-index.htm |
| 2020-08-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120048538/0001209191-20-048538-index.htm |
| 2020-09-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120050511/0001209191-20-050511-index.htm |
| 2020-09-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120051490/0001209191-20-051490-index.htm |
| 2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120052243/0001209191-20-052243-index.htm |
| 2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120052244/0001209191-20-052244-index.htm |
| 2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120052245/0001209191-20-052245-index.htm |
| 2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120052246/0001209191-20-052246-index.htm |
| 2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120052247/0001209191-20-052247-index.htm |
| 2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120052248/0001209191-20-052248-index.htm |
| 2020-10-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120054025/0001209191-20-054025-index.htm |
| 2020-11-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000120919120057311/0001209191-20-057311-index.htm |
| 2018-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1382101/000141588918001458/0001415889-18-001458-index.htm |
| 2018-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1382101/000156459018029555/0001564590-18-029555-index.htm |
| 2019-04-01 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1382101/000156459019010253/0001564590-19-010253-index.htm |
| 2019-04-01 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1382101/000156459019010261/0001564590-19-010261-index.htm |
| 2019-04-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1382101/000156459019010338/0001564590-19-010338-index.htm |
| 2019-04-26 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1382101/000156459019013160/0001564590-19-013160-index.htm |
| 2019-04-26 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1382101/000156459019013167/0001564590-19-013167-index.htm |
| 2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1382101/000156459019016067/0001564590-19-016067-index.htm |
| 2019-05-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1382101/000156459019019236/0001564590-19-019236-index.htm |
| 2019-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1382101/000156459019019255/0001564590-19-019255-index.htm |
| 2019-06-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1382101/000156459019022125/0001564590-19-022125-index.htm |
| 2019-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1382101/000156459019022611/0001564590-19-022611-index.htm |
| 2019-06-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1382101/000156459019023255/0001564590-19-023255-index.htm |
| 2019-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1382101/000156459019031883/0001564590-19-031883-index.htm |
| 2019-08-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1382101/000156459019031936/0001564590-19-031936-index.htm |
| 2019-10-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1382101/000156459019038415/0001564590-19-038415-index.htm |
| 2019-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1382101/000156459019041909/0001564590-19-041909-index.htm |
| 2019-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1382101/000156459019042019/0001564590-19-042019-index.htm |
| 2020-01-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1382101/000156459020000514/0001564590-20-000514-index.htm |
| 2020-03-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1382101/000156459020008232/0001564590-20-008232-index.htm |
| 2020-03-16 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1382101/000156459020010890/0001564590-20-010890-index.htm |
| 2020-03-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1382101/000156459020010955/0001564590-20-010955-index.htm |
| 2020-03-16 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1382101/000156459020011175/0001564590-20-011175-index.htm |
| 2020-04-24 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1382101/000156459020018532/0001564590-20-018532-index.htm |
| 2020-04-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1382101/000156459020018684/0001564590-20-018684-index.htm |
| 2020-05-04 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1382101/000156459020020872/0001564590-20-020872-index.htm |
| 2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1382101/000156459020023689/0001564590-20-023689-index.htm |
| 2020-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1382101/000156459020024242/0001564590-20-024242-index.htm |
| 2020-05-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1382101/000156459020024736/0001564590-20-024736-index.htm |
| 2020-06-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1382101/000156459020028506/0001564590-20-028506-index.htm |
| 2020-06-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1382101/000156459020029235/0001564590-20-029235-index.htm |
| 2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1382101/000156459020036997/0001564590-20-036997-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1382101/000156459020037231/0001564590-20-037231-index.htm |
| 2020-09-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1382101/000156459020042563/0001564590-20-042563-index.htm |
| 2020-09-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1382101/000156459020043014/0001564590-20-043014-index.htm |
| 2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1382101/000156459020050755/0001564590-20-050755-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1382101/000156459020050851/0001564590-20-050851-index.htm |
| 2019-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1382101/000158064219000779/0001580642-19-000779-index.htm |
| 2019-10-11 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1382101/999999999519002305/9999999995-19-002305-index.htm |
Sutro Biopharma, Inc (STRO) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sutro Biopharma, Inc (STRO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1111%Institutional Ownership: 8844%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-09-26 | WILLIAM J NEWELL | CEO | Buy | 25,252.00 | 119,337.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919119051124/0001209191-19-051124-index.htm | ||
| 2020-05-14 | ARTURO MD MOLINA | Chief Medical Officer | Buy | 6,451.00 | 7.75 | 49,995.25 | 12,083.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919120029244/0001209191-20-029244-index.htm |
| 2020-09-25 | EDWARD C ALBINI | CFO and Secretary | Buy | 7,174.00 | 13,556.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919120052243/0001209191-20-052243-index.htm | ||
| 2020-09-25 | Anik Shabbir | Chief Technical Ops. Officer | Buy | 8,609.00 | 14,241.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919120052244/0001209191-20-052244-index.htm | ||
| 2020-08-19 | John Gordon Freund | Director | Sell | 500,000.00 | 8.72 | 4,360,000.00 | 1,460,053.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919120047981/0001209191-20-047981-index.htm |
| 2020-09-25 | LINDA A FITZPATRICK | Chief People & Comm. Officer | Buy | 7,576.00 | 16,583.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919120052245/0001209191-20-052245-index.htm | ||
| 2020-05-14 | WILLIAM J NEWELL | CEO | Buy | 64,516.00 | 7.75 | 499,999.00 | 166,627.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919120029246/0001209191-20-029246-index.htm |
| 2020-08-26 | Trevor Hallam | Chief Scientific Officer | Sell | 975.00 | 9.04 | 8,818.29 | 16,790.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919120048538/0001209191-20-048538-index.htm |
| 2020-07-27 | Trevor Hallam | Chief Science Officer | Sell | 975.00 | 8.06 | 7,858.21 | 17,765.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919120043857/0001209191-20-043857-index.htm |
| 2020-06-26 | Trevor Hallam | Chief Science Officer | Sell | 975.00 | 8.02 | 7,817.65 | 18,740.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919120039220/0001209191-20-039220-index.htm |
| 2020-09-25 | WILLIAM J NEWELL | CEO | Buy | 25,252.00 | 191,879.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919120052248/0001209191-20-052248-index.htm | ||
| 2018-10-01 | Daniel H Petree | Director | Sell | 122.00 | 15.00 | 1,830.00 | 192.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919118052843/0001209191-18-052843-index.htm |
| 2020-05-26 | Trevor Hallam | Chief Science Officer | Sell | 975.00 | 10.00 | 9,753.32 | 19,715.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919120032414/0001209191-20-032414-index.htm |
| 2020-04-27 | Trevor Hallam | Chief Science Officer | Sell | 2.00 | 11.19 | 22.38 | 20,690.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919120025882/0001209191-20-025882-index.htm |
| 2020-09-25 | ARTURO MD MOLINA | Chief Medical Officer | Buy | 8,609.00 | 20,692.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919120052247/0001209191-20-052247-index.htm | ||
| 2020-04-27 | Trevor Hallam | Chief Science Officer | Sell | 973.00 | 9.41 | 9,160.50 | 20,692.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919120025882/0001209191-20-025882-index.htm |
| 2020-03-26 | Trevor Hallam | Chief Science Officer | Sell | 975.00 | 9.69 | 9,452.53 | 21,665.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919120021438/0001209191-20-021438-index.htm |
| 2020-02-26 | Trevor Hallam | Chief Science Officer | Sell | 975.00 | 10.47 | 10,207.28 | 22,640.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919120013478/0001209191-20-013478-index.htm |
| 2020-01-27 | Trevor Hallam | Chief Science Officer | Sell | 975.00 | 10.51 | 10,250.37 | 23,615.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919120005159/0001209191-20-005159-index.htm |
| 2019-12-26 | Trevor Hallam | Chief Science Officer | Sell | 975.00 | 11.08 | 10,802.22 | 24,590.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919119062036/0001209191-19-062036-index.htm |
| 2019-11-26 | Trevor Hallam | Chief Science Officer | Sell | 975.00 | 10.68 | 10,410.27 | 25,565.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919119058353/0001209191-19-058353-index.htm |
| 2019-10-28 | Trevor Hallam | Chief Science Officer | Sell | 975.00 | 9.98 | 9,726.11 | 26,540.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919119054572/0001209191-19-054572-index.htm |
| 2019-09-26 | Trevor Hallam | Chief Science Officer | Buy | 11,019.00 | 26,819.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919119051119/0001209191-19-051119-index.htm | ||
| 2018-10-01 | Merck & Co., Inc. | 10% Share Holder | Buy | 666,666.00 | 15.00 | 9,999,990.00 | 2,723,509.00 | https://www.sec.gov/Archives/edgar/data/1382101/000110465918059933/0001104659-18-059933-index.htm |
| 2020-09-28 | Trevor Hallam | Chief Scientific Officer | Sell | 975.00 | 10.26 | 10,006.72 | 27,530.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919120052246/0001209191-20-052246-index.htm |
| 2020-09-25 | Trevor Hallam | Chief Scientific Officer | Buy | 11,019.00 | 27,809.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919120052246/0001209191-20-052246-index.htm | ||
| 2019-09-26 | Trevor Hallam | Chief Science Officer | Buy | 6,887.00 | 29,896.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919119051119/0001209191-19-051119-index.htm | ||
| 2019-02-12 | Daniel H Petree | Director | Buy | 3,030.00 | 5.09 | 15,422.70 | 3,030.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919119010244/0001209191-19-010244-index.htm |
| 2020-09-25 | Trevor Hallam | Chief Scientific Officer | Buy | 6,887.00 | 30,886.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919120052246/0001209191-20-052246-index.htm | ||
| 2018-10-01 | Daniel H Petree | Director | Buy | 314.00 | 5.81 | 1,824.34 | 314.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919118052843/0001209191-18-052843-index.htm |
| 2020-10-05 | Trevor Hallam | Chief Scientific Officer | Buy | 9,182.00 | 4.36 | 40,033.52 | 36,712.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919120054025/0001209191-20-054025-index.htm |
| 2020-11-05 | Trevor Hallam | Chief Scientific Officer | Sell | 16,751.00 | 15.00 | 251,265.00 | 36,712.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919120057311/0001209191-20-057311-index.htm |
| 2019-09-06 | Daniel H Petree | Director | Buy | 826.00 | 5.09 | 4,204.34 | 3,856.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919119048831/0001209191-19-048831-index.htm |
| 2020-11-05 | Trevor Hallam | Chief Scientific Officer | Buy | 16,751.00 | 4.36 | 73,034.36 | 53,463.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919120057311/0001209191-20-057311-index.htm |
| 2020-09-18 | John Gordon Freund | Director | Sell | 400,000.00 | 12.00 | 4,800,000.00 | 560,053.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919120051490/0001209191-20-051490-index.htm |
| 2019-08-29 | LINDA A FITZPATRICK | Chief People & Comm. Officer | Buy | 826.00 | 5.09 | 4,204.34 | 826.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919119047755/0001209191-19-047755-index.htm |
| 2019-09-26 | LINDA A FITZPATRICK | Chief People & Comm. Officer | Buy | 7,575.00 | 8,401.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919119051118/0001209191-19-051118-index.htm | ||
| 2019-09-26 | Anik Shabbir | Chief Technical Ops. Officer | Buy | 8,608.00 | 8,608.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919119051117/0001209191-19-051117-index.htm | ||
| 2019-09-26 | ARTURO MD MOLINA | Chief Medical Officer | Buy | 8,608.00 | 8,608.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919119051122/0001209191-19-051122-index.htm | ||
| 2019-09-26 | EDWARD C ALBINI | CFO and Secretary | Buy | 7,174.00 | 8,862.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919119051116/0001209191-19-051116-index.htm | ||
| 2020-05-14 | LINDA A FITZPATRICK | Chief People & Comm. Officer | Buy | 3,225.00 | 7.75 | 24,993.75 | 9,007.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919120029243/0001209191-20-029243-index.htm |
| 2020-09-11 | John Gordon Freund | Director | Sell | 500,000.00 | 10.00 | 5,000,000.00 | 960,053.00 | https://www.sec.gov/Archives/edgar/data/1382101/000120919120050511/0001209191-20-050511-index.htm |